487 related articles for article (PubMed ID: 9030663)
21. Immunogenicity of synthetic peptides derived from Plasmodium falciparum proteins.
Zerpa NC; Wide A; Noda J; Bermúdez H; Pabón R; Noya OO
Exp Parasitol; 2006 Aug; 113(4):227-34. PubMed ID: 16513113
[TBL] [Abstract][Full Text] [Related]
22. High immunogenecity and erythrocyte-binding activity in the tryptophan-rich domain (TRD) of the 74-kDa Plasmodium vivax alanine-tryptophan-rich antigen (PvATRAg74).
Alam MT; Bora H; Singh N; Sharma YD
Vaccine; 2008 Jul; 26(31):3787-94. PubMed ID: 18579264
[TBL] [Abstract][Full Text] [Related]
23. Cross-reactivity studies of an anti-Plasmodium vivax apical membrane antigen 1 monoclonal antibody: binding and structural characterisation.
Igonet S; Vulliez-Le Normand B; Faure G; Riottot MM; Kocken CH; Thomas AW; Bentley GA
J Mol Biol; 2007 Mar; 366(5):1523-37. PubMed ID: 17229439
[TBL] [Abstract][Full Text] [Related]
24. Plasmodium falciparum: a comparison of the activity of Pfs230-specific antibodies in an assay of transmission-blocking immunity and specific competition ELISAs.
Roeffen W; Beckers PJ; Teelen K; Lensen T; Sauerwein RW; Meuwissen JH; Eling W
Exp Parasitol; 1995 Feb; 80(1):15-26. PubMed ID: 7529717
[TBL] [Abstract][Full Text] [Related]
25. Immunogenicity of recombinant BCG-based vaccine expressing the 22 kDa of serine repeat antigen (SE22) of Plasmodium falciparum.
Teo WH; Nurul AA; Norazmi MN
Trop Biomed; 2012 Jun; 29(2):239-53. PubMed ID: 22735846
[TBL] [Abstract][Full Text] [Related]
26. Immune response to a synthetic peptide corresponding to an epitope of a parasitophorous vacuole membrane antigen from Plasmodium falciparum.
Kara U; Pye D; Lord R; Pam C; Gould H; Geysen M; Jones G; Stenzel D; Kidson C; Saul A
J Immunol; 1989 Aug; 143(4):1334-9. PubMed ID: 2473129
[TBL] [Abstract][Full Text] [Related]
27. [Preliminary study of a recombinant polyvalent vaccine of Plasmodium falciparum and its immunological activity].
Li Q; Li Y; Xie Y
Zhonghua Yi Xue Za Zhi; 1995 Jun; 75(6):325-8, 381. PubMed ID: 7553140
[TBL] [Abstract][Full Text] [Related]
28. Amino acid dimorphism and parasite immune evasion: cellular immune responses to a promiscuous epitope of Plasmodium falciparum merozoite surface protein 1 displaying dimorphic amino acid polymorphism are highly constrained.
Daubenberger CA; Nickel B; Ciatto C; Grütter MG; Pöltl-Frank F; Rossi L; Siegler U; Robinson J; Kashala O; Patarroyo ME; Pluschke G
Eur J Immunol; 2002 Dec; 32(12):3667-77. PubMed ID: 12516559
[TBL] [Abstract][Full Text] [Related]
29. Overcoming antigenic diversity by enhancing the immunogenicity of conserved epitopes on the malaria vaccine candidate apical membrane antigen-1.
Dutta S; Dlugosz LS; Drew DR; Ge X; Ababacar D; Rovira YI; Moch JK; Shi M; Long CA; Foley M; Beeson JG; Anders RF; Miura K; Haynes JD; Batchelor AH
PLoS Pathog; 2013; 9(12):e1003840. PubMed ID: 24385910
[TBL] [Abstract][Full Text] [Related]
30. Mode of action of invasion-inhibitory antibodies directed against apical membrane antigen 1 of Plasmodium falciparum.
Dutta S; Haynes JD; Barbosa A; Ware LA; Snavely JD; Moch JK; Thomas AW; Lanar DE
Infect Immun; 2005 Apr; 73(4):2116-22. PubMed ID: 15784553
[TBL] [Abstract][Full Text] [Related]
31. Identification of karyopherin beta as an immunogenic antigen of the malaria parasite using immune mice and human sera.
Mohmmed A; Kishore S; Patra KP; Dasaradhi PV; Malhotra P; Chauhan VS
Parasite Immunol; 2005 May; 27(5):197-203. PubMed ID: 15987343
[TBL] [Abstract][Full Text] [Related]
32. Immunogens containing sequences from antigen Pf332 induce Plasmodium falciparum-reactive antibodies which inhibit parasite growth but not cytoadherence.
Ahlborg N; Iqbal J; Hansson M; Uhlén M; Mattei D; Perlmann P; Stahl S; Berzins K
Parasite Immunol; 1995 Jul; 17(7):341-52. PubMed ID: 8552406
[TBL] [Abstract][Full Text] [Related]
33. Identification of Id1-DBL2X of VAR2CSA as a key domain inducing highly inhibitory and cross-reactive antibodies.
Bordbar B; Tuikue-Ndam N; Bigey P; Doritchamou J; Scherman D; Deloron P
Vaccine; 2012 Feb; 30(7):1343-8. PubMed ID: 22226864
[TBL] [Abstract][Full Text] [Related]
34. Binding of malaria T cell epitopes to DR and DQ molecules in vitro correlates with immunogenicity in vivo: identification of a universal T cell epitope in the Plasmodium falciparum circumsporozoite protein.
Calvo-Calle JM; Hammer J; Sinigaglia F; Clavijo P; Moya-Castro ZR; Nardin EH
J Immunol; 1997 Aug; 159(3):1362-73. PubMed ID: 9233633
[TBL] [Abstract][Full Text] [Related]
35. Identification of minimal CD8+ and CD4+ T cell epitopes in the Plasmodium yoelii hepatocyte erythrocyte protein 17kDa.
Dobaño C; Doolan DL
Mol Immunol; 2007 Apr; 44(11):3037-48. PubMed ID: 17303242
[TBL] [Abstract][Full Text] [Related]
36. Novel monoclonal antibody against truncated C terminal region of Histidine Rich Protein2 (PfHRP2) and its utility for the specific diagnosis of malaria caused by Plasmodium falciparum.
Verma R; Jayaprakash NS; Vijayalakshmi MA; Venkataraman K
Exp Parasitol; 2015 Mar; 150():56-66. PubMed ID: 25592728
[TBL] [Abstract][Full Text] [Related]
37. Expression and immunogenicity of tripeptide repeat region on P190 of Plasmodium falciparum.
Pan W; Yang S; Deng H; Lu D
Chin J Biotechnol; 1994; 10(4):249-56. PubMed ID: 7780021
[TBL] [Abstract][Full Text] [Related]
38. Reactivity of the human monoclonal antibody 33G2 with repeated sequences of three distinct Plasmodium falciparum antigens.
Udomsangpetch R; Carlsson J; Wåhlin B; Holmquist G; Ozaki LS; Scherf A; Mattei D; Mercereau-Puijalon O; Uni S; Aikawa M
J Immunol; 1989 May; 142(10):3620-6. PubMed ID: 2654292
[TBL] [Abstract][Full Text] [Related]
39. Characterisation of an inhibitory monoclonal antibody-defined epitope on a malaria vaccine candidate antigen.
Ramasamy R; Jones G; Lord R
Immunol Lett; 1990 Feb; 23(4):305-9. PubMed ID: 1693361
[TBL] [Abstract][Full Text] [Related]
40. Analysis of human T cell clones specific for conserved peptide sequences within malaria proteins. Paucity of clones responsive to intact parasites.
Quakyi IA; Currier J; Fell A; Taylor DW; Roberts T; Houghten RA; England RD; Berzofsky JA; Miller LH; Good MF
J Immunol; 1994 Sep; 153(5):2082-92. PubMed ID: 8051413
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
